(-)-(4R)-3-(3-BUTENYL)-4-(1,1-DIFLUORO-3-BUTENYL)-1,3-OXAZOLAN-2-ONE
Compound with spectra: 2 NMR
| SpectraBase Compound ID | DEgzLuiVQAE |
|---|---|
| InChI | InChI=1S/C11H15F2NO2/c1-3-5-7-14-9(8-16-10(14)15)11(12,13)6-4-2/h3-4,9H,1-2,5-8H2/t9-/m1/s1 |
| InChIKey | WPPSLUMBXZIOMQ-SECBINFHSA-N |
| Mol Weight | 231.24 g/mol |
| Molecular Formula | C11H15F2NO2 |
| Exact Mass | 231.107085 g/mol |
| Enantiomer InChIKey | WPPSLUMBXZIOMQ-VIFPVBQESA-N |
| Racemate InChIKey | WPPSLUMBXZIOMQ-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
METHYL-3-[(4S)-3-((2E)-4-[[TERT.-BUTYL-(DIMETHYL)-SILYL]-OXY]-3-METHYL-2-BUTENYL)-2-OXO-1,3-OXAZOLIDIN-4-YL]-PROPANOATE
(4S)-3-[(Z)-1-oxopent-3-enyl]-4-(phenylmethyl)-2-oxazolidinone
N-PROPYL-HEXAHYDROBENZOOXAZOLIDINONE
4-tert-Butyl-3-(1-oxo-3-methylpent-4-en-1-yl)-1,3-oxazolidin-2-one isomer
4-tert-Butyl-3-(1-oxo-3-methylpentyl)-1,3-oxazolidin-2-one
(S)-4-Benzyl-3-(pent-4-enoyl)oxazolidin-2-one
2-(benzyloxycarbonylamino)-3,3-difluoro-hex-5-enoic acid ethyl ester
4-tert-Butyl-3-(1,7-dioxo-4,5-dimethylhept-2-en-1-yl)tetrahydro-2-oxazolone
4-tert-Butyl-3-(1,7-dioxo-5-methyloct-2-en-1-yl)tetrahydro-2-oxazolone
(4S)-3-([E]-3-Phenyl-2-propenoyl)-4-isopropyl-2-oxazolidinone
| Title | Journal or Book | Year |
|---|---|---|
| Enantioselective Synthesis of Fluorinated α-Amino Acids and Derivatives in Combination with Ring-Closing Metathesis: Intramolecular π-Stacking Interactions as a Source of Stereocontrol | Organic Letters | 2001 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.